Drug intelligence / Profile preview

Xingqi Tanikal capsule

Development stage: Unknown
Lead developer: Xinjiang Uygur Pharmaceutical
Modality: Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Administration: Oral

Overview

Xingqi Tanikal capsule is a traditional Uyghur medicine (TUM) developed by Xinjiang Uygur Pharmaceutical Co., Ltd. for the treatment of functional constipation. It is specifically indicated for patients with cold-wet or cold-dry temperaments (Mizaj) according to the principles of Uyghur medical theory. The formulation is designed to regulate the body's humors and promote bowel movements. It is currently being evaluated in Phase II clinical trials in China (CTR20222284) to assess its efficacy and safety in adults with functional constipation.

Brand names: Xingqi Tanikal capsule
Other names: Xingqi Tongbian capsule杏芪通便胶囊

Beyond the preview

Go deeper on Xingqi Tanikal capsule.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Xingqi Tanikal capsule.

Explore the full profile